Evidence map›Paper›PMID 27264357›Full record

ArticleExperimental neurology2016

NT-3 promotes proprioceptive axon regeneration when combined with activation of the mTor intrinsic growth pathway but not with reduction of myelin extrinsic inhibitors.

Yingpeng Liu, Lakshmi Kelamangalath, Hyukmin Kim, Seung Baek Han, Xiaoqing Tang, Jinbin Zhai, Jee W Hong, Shen Lin, Young-Jin Son, George M Smith

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yingpeng LiuShriners Hospitals Pediatric Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Lakshmi KelamangalathShriners Hospitals Pediatric Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Hyukmin KimShriners Hospitals Pediatric Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Seung Baek HanShriners Hospitals Pediatric Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Xiaoqing TangShriners Hospitals Pediatric Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Jinbin ZhaiShriners Hospitals Pediatric Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Jee W HongShriners Hospitals Pediatric Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Shen LinShriners Hospitals Pediatric Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Young-Jin SonShriners Hospitals Pediatric Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA.
George M SmithShriners Hospitals Pediatric Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA. Electronic address: george.smith@temple.edu.
Temple University · USTemple University Hospital · US

Funding

Dorsal root injury and repairR01NS079631 · NINDS · TEMPLE UNIV OF THE COMMONWEALTH · PI SON, YOUNG-JIN · 2013 to 2017
$1.7M
Reconstruction of the Nigrostriatal pathwayR01NS060784 · NINDS · UNIVERSITY OF KENTUCKY · PI SMITH, GEORGE M · 2009 to 2013
$1.6M
NINDS NIH HHS R01 NS060784NINDS NIH HHS R01 NS079631
6 · The paper itself

Abstract

Although previous studies have identified several strategies to stimulate regeneration of CNS axons, extensive regeneration and functional recovery have remained a major challenge, particularly for large diameter myelinated axons. Within the CNS, myelin is thought to inhibit axon regeneration, while modulating activity of the mTOR pathway promotes regeneration of injured axons. In this study, we examined NT-3 mediated regeneration of sensory axons through the dorsal root entry zone in a triple knockout of myelin inhibitory proteins or after activation of mTOR using a constitutively active (ca) Rheb in DRG neurons to determine the influence of environmental inhibitory or activation of intrinsic growth pathways could enhance NT-3-mediate regeneration. Loss of myelin inhibitory proteins showed modest enhancement of sensory axon regeneration. In mTOR studies, we found a dramatic age related decrease in the mTOR activation as determined by phosphorylation of the downstream marker S6 ribosomal subunit. Expression of caRheb within adult DRG neurons in vitro increased S6 phosphorylation and doubled the overall length of neurite outgrowth, which was reversed in the presence of rapamycin. In adult female rats, combined expression of caRheb in DRG neurons and NT-3 within the spinal cord increased regeneration of sensory axons almost 3 fold when compared to NT-3 alone. Proprioceptive assessment using a grid runway indicates functionally significant regeneration of large-diameter myelinated sensory afferents. Our results indicate that caRheb-induced increase in mTOR activation enhances neurotrophin-3 induced regeneration of large-diameter myelinated axons.

Indexed as

AnimalsAnimals, NewbornCells, CulturedDisease Models, AnimalEmbryo, MammalianFemaleGanglia, SpinalGene Expression RegulationHyperalgesiaMaleMiceMice, Inbred C57BLMice, TransgenicMyelin-Associated GlycoproteinNerve RegenerationNeurotrophin 3Mag protein, mouseMTOR protein, humanMyelin-Associated GlycoproteinNeurotrophin 3Nogo ProteinsSirolimusTOR Serine-Threonine KinasesAxonal regenerationDorsal root ganglion (DRG)mTOR signaling pathwayNeurotrophin-3 (NT-3)Rheb

Identifiers

PMID27264357
PMCPMC5090983
OpenAlexW2419349349

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.